3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine
C86H54Br2Cl5FN26O2S — CID 158316077
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine
3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine (PubChem CID 158316077) has the molecular formula C86H54Br2Cl5FN26O2S and a molecular weight of 1871.70 g/mol. Its IUPAC name is 3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine.
Molecular Properties
| Compound Name | 3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine |
|---|---|
| PubChem CID | 158316077 |
| Molecular Formula | C86H54Br2Cl5FN26O2S |
| Molecular Weight | 1871.70 g/mol |
| Exact Mass | 1866.14 |
| IUPAC Name | 3-amino-6-(4-chloro-1,3-benzoxazol-6-yl)-5-phenylpyrazine-2-carbonitrile;3-amino-6-(8-chloroquinolin-6-yl)-5-(4-fluorophenyl)pyrazine-2-carbonitrile;3-bromo-5-(4-chloro-1,3-benzothiazol-6-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine;3-bromo-5-(4-chloro-1,3-benzoxazol-6-yl)-6-phenylpyrazin-2-amine;5-(7-chloro-1H-indol-5-yl)-6-(1-methylpyrazol-3-yl)pyrazin-2-amine |
| SMILES | Cn1ccc(-c2nc(N)c(Br)nc2-c2cc(Cl)c3ncsc3c2)n1.Cn1ccc(-c2nc(N)cnc2-c2cc(Cl)c3[nH]ccc3c2)n1.N#Cc1nc(-c2cc(Cl)c3ncccc3c2)c(-c2ccc(F)cc2)nc1N.N#Cc1nc(-c2cc(Cl)c3ncoc3c2)c(-c2ccccc2)nc1N.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3ncoc3c2)nc1Br |
| InChI | InChI=1S/C20H11ClFN5.C18H10ClN5O.C17H10BrClN4O.C16H13ClN6.C15H10BrClN6S/c21-15-9-13(8-12-2-1-7-25-17(12)15)19-18(11-3-5-14(22)6-4-11)27-20(24)16(10-23)26-19;19-12-6-11(7-14-17(12)22-9-25-14)16-15(10-4-2-1-3-5-10)24-18(21)13(8-20)23-16;18-16-17(20)23-13(9-4-2-1-3-5-9)14(22-16)10-6-11(19)15-12(7-10)24-8-21-15;1-23-5-3-12(22-23)16-15(20-8-13(18)21-16)10-6-9-2-4-19-14(9)11(17)7-10;1-23-3-2-9(22-23)13-11(20-14(16)15(18)21-13)7-4-8(17)12-10(5-7)24-6-19-12/h1-9H,(H2,24,27);1-7,9H,(H2,21,24);1-8H,(H2,20,23);2-8,19H,1H3,(H2,18,21);2-6H,1H3,(H2,18,21) |
| InChIKey | GOGVPBHWHQDCOW-UHFFFAOYSA-N |
| XLogP | 21.03 |
| TPSA | 435.85 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 123 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1871.70 |
| LogP ≤ 5 | 21.03 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 28 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158316077 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.